Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.19 - $2.42 $95,795 - $194,810
-80,500 Reduced 61.64%
50,100 $115,000
Q3 2023

Nov 14, 2023

BUY
$1.15 - $1.67 $114 - $167
100 Added 0.08%
130,600 $168,000
Q2 2023

Aug 14, 2023

SELL
$0.79 - $1.43 $23,779 - $43,043
-30,100 Reduced 18.74%
130,500 $172,000
Q1 2023

May 15, 2023

BUY
$0.71 - $1.22 $3,266 - $5,612
4,600 Added 2.95%
160,600 $114,000
Q4 2022

Feb 14, 2023

BUY
$0.5 - $1.01 $2,300 - $4,646
4,600 Added 3.04%
156,000 $117,000
Q3 2022

Nov 14, 2022

SELL
$0.82 - $1.73 $462,722 - $976,232
-564,296 Reduced 78.85%
151,400 $130,000
Q2 2022

Aug 15, 2022

SELL
$0.33 - $1.69 $53,930 - $276,191
-163,427 Reduced 18.59%
715,696 $802,000
Q1 2022

May 16, 2022

BUY
$1.04 - $1.7 $164,663 - $269,161
158,330 Added 21.97%
879,123 $984,000
Q4 2021

Feb 14, 2022

SELL
$1.51 - $2.59 $151,000 - $259,000
-100,000 Reduced 12.18%
720,793 $1.15 Million
Q3 2021

Nov 16, 2021

SELL
$2.2 - $3.17 $1.11 Million - $1.6 Million
-504,260 Reduced 38.06%
820,793 $1.99 Million
Q2 2021

Aug 16, 2021

BUY
$2.94 - $4.08 $152,880 - $212,160
52,000 Added 4.08%
1,325,053 $4.2 Million
Q1 2021

May 17, 2021

BUY
$2.6 - $4.43 $299,137 - $509,684
115,053 Added 9.94%
1,273,053 $4.29 Million
Q4 2020

Feb 16, 2021

BUY
$1.95 - $3.6 $1.59 Million - $2.93 Million
814,805 Added 237.42%
1,158,000 $4.15 Million
Q3 2020

Nov 16, 2020

BUY
$2.55 - $3.29 $875,147 - $1.13 Million
343,195 New
343,195 $1,000

Others Institutions Holding MREO

About Mereo Biopharma Group plc


  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $376M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.